Analyzing the specificity of tumor-reactive T-cell clones derived from a patient with metastatic cutaneous melanoma, a tumor-associated antigen was recently identified, known as PRAME (preferentially expressed antigen in melanoma). Here, PRAME is linked to melanoma.